GO:0033077 | T cell differentiation in thymus | 1.02e-04 | 9.92e-01 | 6.968 | 2 | 2 | 26 |
GO:0000776 | kinetochore | 4.61e-04 | 1.00e+00 | 5.887 | 2 | 4 | 55 |
GO:0097252 | oligodendrocyte apoptotic process | 6.14e-04 | 1.00e+00 | 10.668 | 1 | 1 | 1 |
GO:0051081 | nuclear envelope disassembly | 6.14e-04 | 1.00e+00 | 10.668 | 1 | 1 | 1 |
GO:0000235 | astral microtubule | 6.14e-04 | 1.00e+00 | 10.668 | 1 | 1 | 1 |
GO:0042483 | negative regulation of odontogenesis | 6.14e-04 | 1.00e+00 | 10.668 | 1 | 1 | 1 |
GO:0036035 | osteoclast development | 6.14e-04 | 1.00e+00 | 10.668 | 1 | 1 | 1 |
GO:0051171 | regulation of nitrogen compound metabolic process | 6.14e-04 | 1.00e+00 | 10.668 | 1 | 1 | 1 |
GO:0090343 | positive regulation of cell aging | 6.14e-04 | 1.00e+00 | 10.668 | 1 | 1 | 1 |
GO:0034103 | regulation of tissue remodeling | 6.14e-04 | 1.00e+00 | 10.668 | 1 | 1 | 1 |
GO:0051660 | establishment of centrosome localization | 6.14e-04 | 1.00e+00 | 10.668 | 1 | 1 | 1 |
GO:0046469 | platelet activating factor metabolic process | 6.14e-04 | 1.00e+00 | 10.668 | 1 | 1 | 1 |
GO:0005829 | cytosol | 1.04e-03 | 1.00e+00 | 2.187 | 5 | 58 | 1787 |
GO:0044337 | canonical Wnt signaling pathway involved in positive regulation of apoptotic process | 1.23e-03 | 1.00e+00 | 9.668 | 1 | 1 | 2 |
GO:1901525 | negative regulation of macromitophagy | 1.23e-03 | 1.00e+00 | 9.668 | 1 | 1 | 2 |
GO:0035794 | positive regulation of mitochondrial membrane permeability | 1.23e-03 | 1.00e+00 | 9.668 | 1 | 1 | 2 |
GO:0090403 | oxidative stress-induced premature senescence | 1.23e-03 | 1.00e+00 | 9.668 | 1 | 1 | 2 |
GO:0009798 | axis specification | 1.23e-03 | 1.00e+00 | 9.668 | 1 | 1 | 2 |
GO:0045505 | dynein intermediate chain binding | 1.23e-03 | 1.00e+00 | 9.668 | 1 | 1 | 2 |
GO:0006461 | protein complex assembly | 1.26e-03 | 1.00e+00 | 5.161 | 2 | 3 | 91 |
GO:0007050 | cell cycle arrest | 1.29e-03 | 1.00e+00 | 5.145 | 2 | 3 | 92 |
GO:0008017 | microtubule binding | 1.43e-03 | 1.00e+00 | 5.069 | 2 | 4 | 97 |
GO:0000790 | nuclear chromatin | 1.80e-03 | 1.00e+00 | 4.900 | 2 | 3 | 109 |
GO:0010666 | positive regulation of cardiac muscle cell apoptotic process | 1.84e-03 | 1.00e+00 | 9.083 | 1 | 1 | 3 |
GO:1902108 | regulation of mitochondrial membrane permeability involved in apoptotic process | 1.84e-03 | 1.00e+00 | 9.083 | 1 | 1 | 3 |
GO:0051097 | negative regulation of helicase activity | 1.84e-03 | 1.00e+00 | 9.083 | 1 | 1 | 3 |
GO:0030375 | thyroid hormone receptor coactivator activity | 1.84e-03 | 1.00e+00 | 9.083 | 1 | 1 | 3 |
GO:0035033 | histone deacetylase regulator activity | 1.84e-03 | 1.00e+00 | 9.083 | 1 | 1 | 3 |
GO:0002360 | T cell lineage commitment | 1.84e-03 | 1.00e+00 | 9.083 | 1 | 1 | 3 |
GO:0021540 | corpus callosum morphogenesis | 1.84e-03 | 1.00e+00 | 9.083 | 1 | 1 | 3 |
GO:0019887 | protein kinase regulator activity | 1.84e-03 | 1.00e+00 | 9.083 | 1 | 1 | 3 |
GO:0006974 | cellular response to DNA damage stimulus | 2.21e-03 | 1.00e+00 | 4.750 | 2 | 3 | 121 |
GO:0001667 | ameboidal-type cell migration | 2.46e-03 | 1.00e+00 | 8.668 | 1 | 1 | 4 |
GO:0008090 | retrograde axon cargo transport | 2.46e-03 | 1.00e+00 | 8.668 | 1 | 1 | 4 |
GO:0002326 | B cell lineage commitment | 2.46e-03 | 1.00e+00 | 8.668 | 1 | 1 | 4 |
GO:0070245 | positive regulation of thymocyte apoptotic process | 2.46e-03 | 1.00e+00 | 8.668 | 1 | 1 | 4 |
GO:0007097 | nuclear migration | 3.07e-03 | 1.00e+00 | 8.347 | 1 | 1 | 5 |
GO:0007091 | metaphase/anaphase transition of mitotic cell cycle | 3.07e-03 | 1.00e+00 | 8.347 | 1 | 1 | 5 |
GO:0060770 | negative regulation of epithelial cell proliferation involved in prostate gland development | 3.07e-03 | 1.00e+00 | 8.347 | 1 | 1 | 5 |
GO:0044336 | canonical Wnt signaling pathway involved in negative regulation of apoptotic process | 3.07e-03 | 1.00e+00 | 8.347 | 1 | 1 | 5 |
GO:0031274 | positive regulation of pseudopodium assembly | 3.07e-03 | 1.00e+00 | 8.347 | 1 | 1 | 5 |
GO:0002309 | T cell proliferation involved in immune response | 3.07e-03 | 1.00e+00 | 8.347 | 1 | 1 | 5 |
GO:0031023 | microtubule organizing center organization | 3.07e-03 | 1.00e+00 | 8.347 | 1 | 1 | 5 |
GO:0097371 | MDM2/MDM4 family protein binding | 3.07e-03 | 1.00e+00 | 8.347 | 1 | 1 | 5 |
GO:0031512 | motile primary cilium | 3.07e-03 | 1.00e+00 | 8.347 | 1 | 1 | 5 |
GO:0034452 | dynactin binding | 3.07e-03 | 1.00e+00 | 8.347 | 1 | 1 | 5 |
GO:0030858 | positive regulation of epithelial cell differentiation | 3.68e-03 | 1.00e+00 | 8.083 | 1 | 1 | 6 |
GO:0001961 | positive regulation of cytokine-mediated signaling pathway | 3.68e-03 | 1.00e+00 | 8.083 | 1 | 1 | 6 |
GO:0006983 | ER overload response | 3.68e-03 | 1.00e+00 | 8.083 | 1 | 1 | 6 |
GO:0017145 | stem cell division | 3.68e-03 | 1.00e+00 | 8.083 | 1 | 1 | 6 |
GO:0031497 | chromatin assembly | 3.68e-03 | 1.00e+00 | 8.083 | 1 | 1 | 6 |
GO:0007406 | negative regulation of neuroblast proliferation | 3.68e-03 | 1.00e+00 | 8.083 | 1 | 1 | 6 |
GO:0045670 | regulation of osteoclast differentiation | 4.29e-03 | 1.00e+00 | 7.861 | 1 | 1 | 7 |
GO:0051988 | regulation of attachment of spindle microtubules to kinetochore | 4.29e-03 | 1.00e+00 | 7.861 | 1 | 2 | 7 |
GO:0090399 | replicative senescence | 4.29e-03 | 1.00e+00 | 7.861 | 1 | 2 | 7 |
GO:0001675 | acrosome assembly | 4.29e-03 | 1.00e+00 | 7.861 | 1 | 1 | 7 |
GO:0032319 | regulation of Rho GTPase activity | 4.29e-03 | 1.00e+00 | 7.861 | 1 | 1 | 7 |
GO:0030877 | beta-catenin destruction complex | 4.29e-03 | 1.00e+00 | 7.861 | 1 | 1 | 7 |
GO:0021895 | cerebral cortex neuron differentiation | 4.29e-03 | 1.00e+00 | 7.861 | 1 | 1 | 7 |
GO:0045502 | dynein binding | 4.91e-03 | 1.00e+00 | 7.668 | 1 | 1 | 8 |
GO:0045667 | regulation of osteoblast differentiation | 4.91e-03 | 1.00e+00 | 7.668 | 1 | 1 | 8 |
GO:0000733 | DNA strand renaturation | 4.91e-03 | 1.00e+00 | 7.668 | 1 | 2 | 8 |
GO:0031122 | cytoplasmic microtubule organization | 4.91e-03 | 1.00e+00 | 7.668 | 1 | 2 | 8 |
GO:2000273 | positive regulation of receptor activity | 4.91e-03 | 1.00e+00 | 7.668 | 1 | 1 | 8 |
GO:0031116 | positive regulation of microtubule polymerization | 4.91e-03 | 1.00e+00 | 7.668 | 1 | 1 | 8 |
GO:0009303 | rRNA transcription | 4.91e-03 | 1.00e+00 | 7.668 | 1 | 1 | 8 |
GO:0032886 | regulation of microtubule-based process | 5.52e-03 | 1.00e+00 | 7.499 | 1 | 2 | 9 |
GO:0031571 | mitotic G1 DNA damage checkpoint | 5.52e-03 | 1.00e+00 | 7.499 | 1 | 2 | 9 |
GO:0045295 | gamma-catenin binding | 5.52e-03 | 1.00e+00 | 7.499 | 1 | 1 | 9 |
GO:0044295 | axonal growth cone | 5.52e-03 | 1.00e+00 | 7.499 | 1 | 1 | 9 |
GO:0031065 | positive regulation of histone deacetylation | 5.52e-03 | 1.00e+00 | 7.499 | 1 | 1 | 9 |
GO:0070266 | necroptotic process | 5.52e-03 | 1.00e+00 | 7.499 | 1 | 1 | 9 |
GO:0048854 | brain morphogenesis | 5.52e-03 | 1.00e+00 | 7.499 | 1 | 1 | 9 |
GO:0046902 | regulation of mitochondrial membrane permeability | 5.52e-03 | 1.00e+00 | 7.499 | 1 | 1 | 9 |
GO:0008266 | poly(U) RNA binding | 5.52e-03 | 1.00e+00 | 7.499 | 1 | 1 | 9 |
GO:0005515 | protein binding | 5.66e-03 | 1.00e+00 | 1.244 | 6 | 76 | 4124 |
GO:0043065 | positive regulation of apoptotic process | 6.05e-03 | 1.00e+00 | 4.010 | 2 | 3 | 202 |
GO:0071850 | mitotic cell cycle arrest | 6.13e-03 | 1.00e+00 | 7.347 | 1 | 1 | 10 |
GO:0043409 | negative regulation of MAPK cascade | 6.13e-03 | 1.00e+00 | 7.347 | 1 | 1 | 10 |
GO:0032461 | positive regulation of protein oligomerization | 6.13e-03 | 1.00e+00 | 7.347 | 1 | 1 | 10 |
GO:0009651 | response to salt stress | 6.13e-03 | 1.00e+00 | 7.347 | 1 | 1 | 10 |
GO:0008134 | transcription factor binding | 6.46e-03 | 1.00e+00 | 3.961 | 2 | 4 | 209 |
GO:0043234 | protein complex | 6.52e-03 | 1.00e+00 | 3.954 | 2 | 8 | 210 |
GO:0042273 | ribosomal large subunit biogenesis | 6.74e-03 | 1.00e+00 | 7.209 | 1 | 3 | 11 |
GO:0009306 | protein secretion | 6.74e-03 | 1.00e+00 | 7.209 | 1 | 1 | 11 |
GO:0051010 | microtubule plus-end binding | 6.74e-03 | 1.00e+00 | 7.209 | 1 | 1 | 11 |
GO:0007026 | negative regulation of microtubule depolymerization | 6.74e-03 | 1.00e+00 | 7.209 | 1 | 1 | 11 |
GO:0070935 | 3'-UTR-mediated mRNA stabilization | 6.74e-03 | 1.00e+00 | 7.209 | 1 | 2 | 11 |
GO:0042149 | cellular response to glucose starvation | 6.74e-03 | 1.00e+00 | 7.209 | 1 | 1 | 11 |
GO:0008340 | determination of adult lifespan | 6.74e-03 | 1.00e+00 | 7.209 | 1 | 1 | 11 |
GO:0045120 | pronucleus | 6.74e-03 | 1.00e+00 | 7.209 | 1 | 1 | 11 |
GO:0047496 | vesicle transport along microtubule | 6.74e-03 | 1.00e+00 | 7.209 | 1 | 1 | 11 |
GO:0045773 | positive regulation of axon extension | 6.74e-03 | 1.00e+00 | 7.209 | 1 | 1 | 11 |
GO:0046716 | muscle cell cellular homeostasis | 6.74e-03 | 1.00e+00 | 7.209 | 1 | 1 | 11 |
GO:0048568 | embryonic organ development | 6.74e-03 | 1.00e+00 | 7.209 | 1 | 1 | 11 |
GO:0021819 | layer formation in cerebral cortex | 6.74e-03 | 1.00e+00 | 7.209 | 1 | 1 | 11 |
GO:0005813 | centrosome | 6.95e-03 | 1.00e+00 | 3.907 | 2 | 8 | 217 |
GO:2000378 | negative regulation of reactive oxygen species metabolic process | 7.35e-03 | 1.00e+00 | 7.083 | 1 | 1 | 12 |
GO:0043274 | phospholipase binding | 7.35e-03 | 1.00e+00 | 7.083 | 1 | 1 | 12 |
GO:0051276 | chromosome organization | 7.35e-03 | 1.00e+00 | 7.083 | 1 | 1 | 12 |
GO:0000132 | establishment of mitotic spindle orientation | 7.35e-03 | 1.00e+00 | 7.083 | 1 | 1 | 12 |
GO:0019901 | protein kinase binding | 7.92e-03 | 1.00e+00 | 3.810 | 2 | 11 | 232 |
GO:0035371 | microtubule plus-end | 7.96e-03 | 1.00e+00 | 6.968 | 1 | 1 | 13 |
GO:0010906 | regulation of glucose metabolic process | 7.96e-03 | 1.00e+00 | 6.968 | 1 | 1 | 13 |
GO:0008156 | negative regulation of DNA replication | 7.96e-03 | 1.00e+00 | 6.968 | 1 | 1 | 13 |
GO:0030330 | DNA damage response, signal transduction by p53 class mediator | 7.96e-03 | 1.00e+00 | 6.968 | 1 | 1 | 13 |
GO:0019226 | transmission of nerve impulse | 7.96e-03 | 1.00e+00 | 6.968 | 1 | 1 | 13 |
GO:0002931 | response to ischemia | 7.96e-03 | 1.00e+00 | 6.968 | 1 | 1 | 13 |
GO:0007405 | neuroblast proliferation | 8.57e-03 | 1.00e+00 | 6.861 | 1 | 1 | 14 |
GO:0006978 | DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator | 8.57e-03 | 1.00e+00 | 6.861 | 1 | 1 | 14 |
GO:0051721 | protein phosphatase 2A binding | 8.57e-03 | 1.00e+00 | 6.861 | 1 | 1 | 14 |
GO:0045736 | negative regulation of cyclin-dependent protein serine/threonine kinase activity | 8.57e-03 | 1.00e+00 | 6.861 | 1 | 1 | 14 |
GO:0072332 | intrinsic apoptotic signaling pathway by p53 class mediator | 8.57e-03 | 1.00e+00 | 6.861 | 1 | 1 | 14 |
GO:0003723 | RNA binding | 8.94e-03 | 1.00e+00 | 3.720 | 2 | 11 | 247 |
GO:0016922 | ligand-dependent nuclear receptor binding | 9.18e-03 | 1.00e+00 | 6.762 | 1 | 1 | 15 |
GO:0071158 | positive regulation of cell cycle arrest | 9.18e-03 | 1.00e+00 | 6.762 | 1 | 1 | 15 |
GO:0000281 | mitotic cytokinesis | 9.18e-03 | 1.00e+00 | 6.762 | 1 | 1 | 15 |
GO:0003682 | chromatin binding | 9.29e-03 | 1.00e+00 | 3.691 | 2 | 6 | 252 |
GO:0005657 | replication fork | 9.79e-03 | 1.00e+00 | 6.668 | 1 | 2 | 16 |
GO:0035035 | histone acetyltransferase binding | 1.04e-02 | 1.00e+00 | 6.581 | 1 | 1 | 17 |
GO:0007369 | gastrulation | 1.04e-02 | 1.00e+00 | 6.581 | 1 | 1 | 17 |
GO:0007017 | microtubule-based process | 1.04e-02 | 1.00e+00 | 6.581 | 1 | 1 | 17 |
GO:0010165 | response to X-ray | 1.04e-02 | 1.00e+00 | 6.581 | 1 | 1 | 17 |
GO:0009954 | proximal/distal pattern formation | 1.04e-02 | 1.00e+00 | 6.581 | 1 | 1 | 17 |
GO:0009953 | dorsal/ventral pattern formation | 1.10e-02 | 1.00e+00 | 6.499 | 1 | 1 | 18 |
GO:0005669 | transcription factor TFIID complex | 1.10e-02 | 1.00e+00 | 6.499 | 1 | 1 | 18 |
GO:0090200 | positive regulation of release of cytochrome c from mitochondria | 1.10e-02 | 1.00e+00 | 6.499 | 1 | 1 | 18 |
GO:0048147 | negative regulation of fibroblast proliferation | 1.10e-02 | 1.00e+00 | 6.499 | 1 | 1 | 18 |
GO:0035257 | nuclear hormone receptor binding | 1.10e-02 | 1.00e+00 | 6.499 | 1 | 1 | 18 |
GO:0008285 | negative regulation of cell proliferation | 1.12e-02 | 1.00e+00 | 3.555 | 2 | 4 | 277 |
GO:0016573 | histone acetylation | 1.16e-02 | 1.00e+00 | 6.421 | 1 | 1 | 19 |
GO:0046329 | negative regulation of JNK cascade | 1.16e-02 | 1.00e+00 | 6.421 | 1 | 1 | 19 |
GO:0021549 | cerebellum development | 1.16e-02 | 1.00e+00 | 6.421 | 1 | 1 | 19 |
GO:0000060 | protein import into nucleus, translocation | 1.16e-02 | 1.00e+00 | 6.421 | 1 | 1 | 19 |
GO:0005654 | nucleoplasm | 1.17e-02 | 1.00e+00 | 2.479 | 3 | 55 | 876 |
GO:0043044 | ATP-dependent chromatin remodeling | 1.22e-02 | 1.00e+00 | 6.347 | 1 | 2 | 20 |
GO:0045296 | cadherin binding | 1.22e-02 | 1.00e+00 | 6.347 | 1 | 1 | 20 |
GO:0010977 | negative regulation of neuron projection development | 1.28e-02 | 1.00e+00 | 6.276 | 1 | 1 | 21 |
GO:0007569 | cell aging | 1.28e-02 | 1.00e+00 | 6.276 | 1 | 2 | 21 |
GO:0001942 | hair follicle development | 1.28e-02 | 1.00e+00 | 6.276 | 1 | 1 | 21 |
GO:2000379 | positive regulation of reactive oxygen species metabolic process | 1.28e-02 | 1.00e+00 | 6.276 | 1 | 1 | 21 |
GO:0051781 | positive regulation of cell division | 1.34e-02 | 1.00e+00 | 6.209 | 1 | 1 | 22 |
GO:0005875 | microtubule associated complex | 1.34e-02 | 1.00e+00 | 6.209 | 1 | 1 | 22 |
GO:0001836 | release of cytochrome c from mitochondria | 1.34e-02 | 1.00e+00 | 6.209 | 1 | 1 | 22 |
GO:0045931 | positive regulation of mitotic cell cycle | 1.41e-02 | 1.00e+00 | 6.145 | 1 | 1 | 23 |
GO:0051262 | protein tetramerization | 1.41e-02 | 1.00e+00 | 6.145 | 1 | 2 | 23 |
GO:0016604 | nuclear body | 1.41e-02 | 1.00e+00 | 6.145 | 1 | 1 | 23 |
GO:0031252 | cell leading edge | 1.47e-02 | 1.00e+00 | 6.083 | 1 | 1 | 24 |
GO:0005881 | cytoplasmic microtubule | 1.47e-02 | 1.00e+00 | 6.083 | 1 | 1 | 24 |
GO:1900740 | positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway | 1.47e-02 | 1.00e+00 | 6.083 | 1 | 1 | 24 |
GO:0046677 | response to antibiotic | 1.47e-02 | 1.00e+00 | 6.083 | 1 | 1 | 24 |
GO:0007611 | learning or memory | 1.47e-02 | 1.00e+00 | 6.083 | 1 | 1 | 24 |
GO:0042771 | intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator | 1.47e-02 | 1.00e+00 | 6.083 | 1 | 1 | 24 |
GO:0071479 | cellular response to ionizing radiation | 1.47e-02 | 1.00e+00 | 6.083 | 1 | 1 | 24 |
GO:0005913 | cell-cell adherens junction | 1.53e-02 | 1.00e+00 | 6.025 | 1 | 1 | 25 |
GO:0051219 | phosphoprotein binding | 1.53e-02 | 1.00e+00 | 6.025 | 1 | 2 | 25 |
GO:0003730 | mRNA 3'-UTR binding | 1.53e-02 | 1.00e+00 | 6.025 | 1 | 2 | 25 |
GO:0048538 | thymus development | 1.53e-02 | 1.00e+00 | 6.025 | 1 | 1 | 25 |
GO:0007094 | mitotic spindle assembly checkpoint | 1.53e-02 | 1.00e+00 | 6.025 | 1 | 3 | 25 |
GO:0031492 | nucleosomal DNA binding | 1.53e-02 | 1.00e+00 | 6.025 | 1 | 2 | 25 |
GO:0034613 | cellular protein localization | 1.59e-02 | 1.00e+00 | 5.968 | 1 | 1 | 26 |
GO:0030971 | receptor tyrosine kinase binding | 1.59e-02 | 1.00e+00 | 5.968 | 1 | 1 | 26 |
GO:0010332 | response to gamma radiation | 1.59e-02 | 1.00e+00 | 5.968 | 1 | 1 | 26 |
GO:0016042 | lipid catabolic process | 1.59e-02 | 1.00e+00 | 5.968 | 1 | 1 | 26 |
GO:0001756 | somitogenesis | 1.65e-02 | 1.00e+00 | 5.914 | 1 | 1 | 27 |
GO:0034644 | cellular response to UV | 1.71e-02 | 1.00e+00 | 5.861 | 1 | 2 | 28 |
GO:2001244 | positive regulation of intrinsic apoptotic signaling pathway | 1.71e-02 | 1.00e+00 | 5.861 | 1 | 1 | 28 |
GO:0050885 | neuromuscular process controlling balance | 1.71e-02 | 1.00e+00 | 5.861 | 1 | 1 | 28 |
GO:0045785 | positive regulation of cell adhesion | 1.77e-02 | 1.00e+00 | 5.810 | 1 | 1 | 29 |
GO:0005507 | copper ion binding | 1.77e-02 | 1.00e+00 | 5.810 | 1 | 1 | 29 |
GO:0070830 | tight junction assembly | 1.77e-02 | 1.00e+00 | 5.810 | 1 | 1 | 29 |
GO:0042802 | identical protein binding | 1.78e-02 | 1.00e+00 | 3.201 | 2 | 7 | 354 |
GO:0051402 | neuron apoptotic process | 1.83e-02 | 1.00e+00 | 5.762 | 1 | 2 | 30 |
GO:0001228 | RNA polymerase II transcription regulatory region sequence-specific DNA binding transcription factor activity involved in positive regulation of transcription | 1.83e-02 | 1.00e+00 | 5.762 | 1 | 1 | 30 |
GO:0021987 | cerebral cortex development | 1.83e-02 | 1.00e+00 | 5.762 | 1 | 2 | 30 |
GO:0030374 | ligand-dependent nuclear receptor transcription coactivator activity | 1.83e-02 | 1.00e+00 | 5.762 | 1 | 2 | 30 |
GO:0004402 | histone acetyltransferase activity | 1.83e-02 | 1.00e+00 | 5.762 | 1 | 1 | 30 |
GO:0021766 | hippocampus development | 1.89e-02 | 1.00e+00 | 5.714 | 1 | 2 | 31 |
GO:0016328 | lateral plasma membrane | 1.89e-02 | 1.00e+00 | 5.714 | 1 | 1 | 31 |
GO:0006921 | cellular component disassembly involved in execution phase of apoptosis | 1.89e-02 | 1.00e+00 | 5.714 | 1 | 1 | 31 |
GO:0005871 | kinesin complex | 1.89e-02 | 1.00e+00 | 5.714 | 1 | 2 | 31 |
GO:0008104 | protein localization | 1.89e-02 | 1.00e+00 | 5.714 | 1 | 2 | 31 |
GO:0001085 | RNA polymerase II transcription factor binding | 1.89e-02 | 1.00e+00 | 5.714 | 1 | 1 | 31 |
GO:0006284 | base-excision repair | 1.95e-02 | 1.00e+00 | 5.668 | 1 | 8 | 32 |
GO:0035019 | somatic stem cell maintenance | 1.95e-02 | 1.00e+00 | 5.668 | 1 | 1 | 32 |
GO:0008344 | adult locomotory behavior | 2.01e-02 | 1.00e+00 | 5.624 | 1 | 1 | 33 |
GO:0060041 | retina development in camera-type eye | 2.07e-02 | 1.00e+00 | 5.581 | 1 | 2 | 34 |
GO:0045732 | positive regulation of protein catabolic process | 2.07e-02 | 1.00e+00 | 5.581 | 1 | 1 | 34 |
GO:0000226 | microtubule cytoskeleton organization | 2.19e-02 | 1.00e+00 | 5.499 | 1 | 2 | 36 |
GO:0022625 | cytosolic large ribosomal subunit | 2.19e-02 | 1.00e+00 | 5.499 | 1 | 2 | 36 |
GO:0035690 | cellular response to drug | 2.31e-02 | 1.00e+00 | 5.421 | 1 | 2 | 38 |
GO:0006915 | apoptotic process | 2.37e-02 | 1.00e+00 | 2.985 | 2 | 21 | 411 |
GO:0000979 | RNA polymerase II core promoter sequence-specific DNA binding | 2.43e-02 | 1.00e+00 | 5.347 | 1 | 2 | 40 |
GO:0043525 | positive regulation of neuron apoptotic process | 2.49e-02 | 1.00e+00 | 5.311 | 1 | 1 | 41 |
GO:0003684 | damaged DNA binding | 2.49e-02 | 1.00e+00 | 5.311 | 1 | 9 | 41 |
GO:0016032 | viral process | 2.56e-02 | 1.00e+00 | 2.927 | 2 | 32 | 428 |
GO:0051087 | chaperone binding | 2.73e-02 | 1.00e+00 | 5.177 | 1 | 3 | 45 |
GO:0002039 | p53 binding | 2.73e-02 | 1.00e+00 | 5.177 | 1 | 2 | 45 |
GO:0007409 | axonogenesis | 2.73e-02 | 1.00e+00 | 5.177 | 1 | 1 | 45 |
GO:0008013 | beta-catenin binding | 2.73e-02 | 1.00e+00 | 5.177 | 1 | 1 | 45 |
GO:0019903 | protein phosphatase binding | 2.85e-02 | 1.00e+00 | 5.114 | 1 | 3 | 47 |
GO:0000122 | negative regulation of transcription from RNA polymerase II promoter | 2.88e-02 | 1.00e+00 | 2.836 | 2 | 4 | 456 |
GO:0097193 | intrinsic apoptotic signaling pathway | 2.97e-02 | 1.00e+00 | 5.054 | 1 | 1 | 49 |
GO:0000980 | RNA polymerase II distal enhancer sequence-specific DNA binding | 2.97e-02 | 1.00e+00 | 5.054 | 1 | 3 | 49 |
GO:0002020 | protease binding | 3.03e-02 | 1.00e+00 | 5.025 | 1 | 1 | 50 |
GO:0032587 | ruffle membrane | 3.03e-02 | 1.00e+00 | 5.025 | 1 | 1 | 50 |
GO:0060070 | canonical Wnt signaling pathway | 3.09e-02 | 1.00e+00 | 4.996 | 1 | 1 | 51 |
GO:0001822 | kidney development | 3.15e-02 | 1.00e+00 | 4.968 | 1 | 1 | 52 |
GO:0006302 | double-strand break repair | 3.15e-02 | 1.00e+00 | 4.968 | 1 | 8 | 52 |
GO:0006289 | nucleotide-excision repair | 3.21e-02 | 1.00e+00 | 4.941 | 1 | 9 | 53 |
GO:0006977 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest | 3.21e-02 | 1.00e+00 | 4.941 | 1 | 17 | 53 |
GO:0030512 | negative regulation of transforming growth factor beta receptor signaling pathway | 3.21e-02 | 1.00e+00 | 4.941 | 1 | 1 | 53 |
GO:0035264 | multicellular organism growth | 3.27e-02 | 1.00e+00 | 4.914 | 1 | 1 | 54 |
GO:0005681 | spliceosomal complex | 3.33e-02 | 1.00e+00 | 4.887 | 1 | 2 | 55 |
GO:0050731 | positive regulation of peptidyl-tyrosine phosphorylation | 3.39e-02 | 1.00e+00 | 4.861 | 1 | 1 | 56 |
GO:0090090 | negative regulation of canonical Wnt signaling pathway | 3.57e-02 | 1.00e+00 | 4.786 | 1 | 2 | 59 |
GO:0000785 | chromatin | 3.57e-02 | 1.00e+00 | 4.786 | 1 | 5 | 59 |
GO:0007265 | Ras protein signal transduction | 3.57e-02 | 1.00e+00 | 4.786 | 1 | 3 | 59 |
GO:0009952 | anterior/posterior pattern specification | 3.63e-02 | 1.00e+00 | 4.762 | 1 | 1 | 60 |
GO:0019083 | viral transcription | 3.69e-02 | 1.00e+00 | 4.738 | 1 | 2 | 61 |
GO:0071013 | catalytic step 2 spliceosome | 3.69e-02 | 1.00e+00 | 4.738 | 1 | 5 | 61 |
GO:0006415 | translational termination | 3.81e-02 | 1.00e+00 | 4.691 | 1 | 2 | 63 |
GO:0030426 | growth cone | 3.87e-02 | 1.00e+00 | 4.668 | 1 | 1 | 64 |
GO:0005923 | tight junction | 3.87e-02 | 1.00e+00 | 4.668 | 1 | 2 | 64 |
GO:0010467 | gene expression | 3.88e-02 | 1.00e+00 | 2.605 | 2 | 31 | 535 |
GO:0047485 | protein N-terminus binding | 3.93e-02 | 1.00e+00 | 4.646 | 1 | 2 | 65 |
GO:0001764 | neuron migration | 4.05e-02 | 1.00e+00 | 4.602 | 1 | 1 | 67 |
GO:0006364 | rRNA processing | 4.05e-02 | 1.00e+00 | 4.602 | 1 | 4 | 67 |
GO:0006414 | translational elongation | 4.17e-02 | 1.00e+00 | 4.560 | 1 | 2 | 69 |
GO:0030308 | negative regulation of cell growth | 4.23e-02 | 1.00e+00 | 4.539 | 1 | 2 | 70 |
GO:0016363 | nuclear matrix | 4.40e-02 | 1.00e+00 | 4.479 | 1 | 7 | 73 |
GO:0001649 | osteoblast differentiation | 4.46e-02 | 1.00e+00 | 4.459 | 1 | 2 | 74 |
GO:0071456 | cellular response to hypoxia | 4.58e-02 | 1.00e+00 | 4.421 | 1 | 2 | 76 |
GO:0006614 | SRP-dependent cotranslational protein targeting to membrane | 4.64e-02 | 1.00e+00 | 4.402 | 1 | 2 | 77 |
GO:0005938 | cell cortex | 4.64e-02 | 1.00e+00 | 4.402 | 1 | 1 | 77 |
GO:0019058 | viral life cycle | 4.70e-02 | 1.00e+00 | 4.383 | 1 | 3 | 78 |
GO:0016605 | PML body | 4.76e-02 | 1.00e+00 | 4.365 | 1 | 4 | 79 |
GO:0005737 | cytoplasm | 4.89e-02 | 1.00e+00 | 1.306 | 4 | 50 | 2633 |
GO:0005635 | nuclear envelope | 4.99e-02 | 1.00e+00 | 4.293 | 1 | 4 | 83 |
GO:0000184 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay | 5.05e-02 | 1.00e+00 | 4.276 | 1 | 3 | 84 |
GO:0030027 | lamellipodium | 5.29e-02 | 1.00e+00 | 4.209 | 1 | 1 | 88 |
GO:0044255 | cellular lipid metabolic process | 5.35e-02 | 1.00e+00 | 4.193 | 1 | 2 | 89 |
GO:0030036 | actin cytoskeleton organization | 5.41e-02 | 1.00e+00 | 4.177 | 1 | 1 | 90 |
GO:0045944 | positive regulation of transcription from RNA polymerase II promoter | 5.45e-02 | 1.00e+00 | 2.338 | 2 | 8 | 644 |
GO:0008201 | heparin binding | 5.46e-02 | 1.00e+00 | 4.161 | 1 | 1 | 91 |
GO:0046983 | protein dimerization activity | 5.64e-02 | 1.00e+00 | 4.114 | 1 | 1 | 94 |
GO:0007219 | Notch signaling pathway | 5.70e-02 | 1.00e+00 | 4.099 | 1 | 4 | 95 |
GO:0016477 | cell migration | 5.76e-02 | 1.00e+00 | 4.083 | 1 | 2 | 96 |
GO:0000086 | G2/M transition of mitotic cell cycle | 5.82e-02 | 1.00e+00 | 4.069 | 1 | 5 | 97 |
GO:0006413 | translational initiation | 5.93e-02 | 1.00e+00 | 4.039 | 1 | 4 | 99 |
GO:0030335 | positive regulation of cell migration | 6.05e-02 | 1.00e+00 | 4.010 | 1 | 1 | 101 |
GO:0070062 | extracellular vesicular exosome | 6.36e-02 | 1.00e+00 | 1.573 | 3 | 43 | 1641 |
GO:0007179 | transforming growth factor beta receptor signaling pathway | 6.40e-02 | 1.00e+00 | 3.927 | 1 | 1 | 107 |
GO:0003735 | structural constituent of ribosome | 6.51e-02 | 1.00e+00 | 3.900 | 1 | 2 | 109 |
GO:0006355 | regulation of transcription, DNA-templated | 6.59e-02 | 1.00e+00 | 2.187 | 2 | 7 | 715 |
GO:0042981 | regulation of apoptotic process | 6.69e-02 | 1.00e+00 | 3.861 | 1 | 18 | 112 |
GO:0000398 | mRNA splicing, via spliceosome | 7.61e-02 | 1.00e+00 | 3.668 | 1 | 8 | 128 |
GO:0030424 | axon | 7.61e-02 | 1.00e+00 | 3.668 | 1 | 2 | 128 |
GO:0031965 | nuclear membrane | 7.73e-02 | 1.00e+00 | 3.646 | 1 | 3 | 130 |
GO:0001077 | RNA polymerase II core promoter proximal region sequence-specific DNA binding transcription factor activity involved in positive regulation of transcription | 7.84e-02 | 1.00e+00 | 3.624 | 1 | 1 | 132 |
GO:0044822 | poly(A) RNA binding | 8.04e-02 | 1.00e+00 | 2.026 | 2 | 25 | 799 |
GO:0031625 | ubiquitin protein ligase binding | 8.19e-02 | 1.00e+00 | 3.560 | 1 | 5 | 138 |
GO:0005759 | mitochondrial matrix | 8.24e-02 | 1.00e+00 | 3.550 | 1 | 5 | 139 |
GO:0000978 | RNA polymerase II core promoter proximal region sequence-specific DNA binding | 8.42e-02 | 1.00e+00 | 3.519 | 1 | 2 | 142 |
GO:0044212 | transcription regulatory region DNA binding | 8.47e-02 | 1.00e+00 | 3.509 | 1 | 2 | 143 |
GO:0004871 | signal transducer activity | 8.76e-02 | 1.00e+00 | 3.459 | 1 | 1 | 148 |
GO:0001701 | in utero embryonic development | 9.10e-02 | 1.00e+00 | 3.402 | 1 | 3 | 154 |
GO:0007067 | mitotic nuclear division | 9.72e-02 | 1.00e+00 | 3.302 | 1 | 8 | 165 |
GO:0008380 | RNA splicing | 9.72e-02 | 1.00e+00 | 3.302 | 1 | 7 | 165 |
GO:0016071 | mRNA metabolic process | 1.00e-01 | 1.00e+00 | 3.259 | 1 | 21 | 170 |
GO:0043025 | neuronal cell body | 1.01e-01 | 1.00e+00 | 3.251 | 1 | 3 | 171 |
GO:0000166 | nucleotide binding | 1.03e-01 | 1.00e+00 | 3.209 | 1 | 6 | 176 |
GO:0006412 | translation | 1.05e-01 | 1.00e+00 | 3.193 | 1 | 3 | 178 |
GO:0003713 | transcription coactivator activity | 1.08e-01 | 1.00e+00 | 3.145 | 1 | 5 | 184 |
GO:0016070 | RNA metabolic process | 1.10e-01 | 1.00e+00 | 3.114 | 1 | 21 | 188 |
GO:0030154 | cell differentiation | 1.19e-01 | 1.00e+00 | 2.996 | 1 | 3 | 204 |
GO:0019899 | enzyme binding | 1.22e-01 | 1.00e+00 | 2.954 | 1 | 4 | 210 |
GO:0007268 | synaptic transmission | 1.25e-01 | 1.00e+00 | 2.927 | 1 | 1 | 214 |
GO:0007275 | multicellular organismal development | 1.25e-01 | 1.00e+00 | 2.927 | 1 | 4 | 214 |
GO:0008283 | cell proliferation | 1.38e-01 | 1.00e+00 | 2.768 | 1 | 6 | 239 |
GO:0007155 | cell adhesion | 1.41e-01 | 1.00e+00 | 2.738 | 1 | 2 | 244 |
GO:0046982 | protein heterodimerization activity | 1.52e-01 | 1.00e+00 | 2.619 | 1 | 5 | 265 |
GO:0016020 | membrane | 1.63e-01 | 1.00e+00 | 1.431 | 2 | 38 | 1207 |
GO:0005730 | nucleolus | 1.66e-01 | 1.00e+00 | 1.419 | 2 | 41 | 1217 |
GO:0000278 | mitotic cell cycle | 1.78e-01 | 1.00e+00 | 2.374 | 1 | 35 | 314 |
GO:0045892 | negative regulation of transcription, DNA-templated | 1.80e-01 | 1.00e+00 | 2.360 | 1 | 7 | 317 |
GO:0043066 | negative regulation of apoptotic process | 1.82e-01 | 1.00e+00 | 2.338 | 1 | 20 | 322 |
GO:0007596 | blood coagulation | 1.91e-01 | 1.00e+00 | 2.263 | 1 | 4 | 339 |
GO:0048471 | perinuclear region of cytoplasm | 1.94e-01 | 1.00e+00 | 2.242 | 1 | 5 | 344 |
GO:0044267 | cellular protein metabolic process | 1.98e-01 | 1.00e+00 | 2.209 | 1 | 5 | 352 |
GO:0045893 | positive regulation of transcription, DNA-templated | 2.10e-01 | 1.00e+00 | 2.110 | 1 | 10 | 377 |
GO:0005783 | endoplasmic reticulum | 2.12e-01 | 1.00e+00 | 2.095 | 1 | 3 | 381 |
GO:0042803 | protein homodimerization activity | 2.36e-01 | 1.00e+00 | 1.927 | 1 | 5 | 428 |
GO:0003700 | sequence-specific DNA binding transcription factor activity | 3.08e-01 | 1.00e+00 | 1.484 | 1 | 6 | 582 |
GO:0005634 | nucleus | 3.18e-01 | 1.00e+00 | 0.589 | 3 | 67 | 3246 |
GO:0007165 | signal transduction | 3.25e-01 | 1.00e+00 | 1.397 | 1 | 5 | 618 |
GO:0005739 | mitochondrion | 3.43e-01 | 1.00e+00 | 1.304 | 1 | 11 | 659 |
GO:0008270 | zinc ion binding | 3.71e-01 | 1.00e+00 | 1.163 | 1 | 7 | 727 |
GO:0044281 | small molecule metabolic process | 4.19e-01 | 1.00e+00 | 0.947 | 1 | 32 | 844 |
GO:0005524 | ATP binding | 4.37e-01 | 1.00e+00 | 0.868 | 1 | 23 | 892 |
GO:0003677 | DNA binding | 4.58e-01 | 1.00e+00 | 0.781 | 1 | 18 | 947 |
GO:0006351 | transcription, DNA-templated | 5.04e-01 | 1.00e+00 | 0.597 | 1 | 9 | 1076 |
GO:0005886 | plasma membrane | 7.02e-01 | 1.00e+00 | -0.132 | 1 | 11 | 1784 |